Smeal Tod has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 300000 shares of Cardiff Oncology, Inc. ($CRDF) on April 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 14, 2026 | Cardiff Oncology, Inc. | $CRDF | Smeal Tod | Chief Scientific Officer | A | Stock Options | 300000 | $0.00 | 1,279,805.0000 | 67,360,564 | 30.62% | 0.45% |
| March 11, 2025 | Cardiff Oncology, Inc. | $CRDF | Smeal Tod | Chief Scientific Officer | A | Stock Options | 332621 | $0.00 | 979,805.0000 | 66,524,294 | 51.40% | 0.50% |
| March 7, 2024 | Cardiff Oncology, Inc. | $CRDF | Smeal Tod | Chief Scientific Officer | A | Stock Options | 205008 | $0.00 | 647,184.0000 | 0 | 46.36% | 0.00% |
| March 15, 2023 | Cardiff Oncology, Inc. | $CRDF | Smeal Tod | Chief Scientific Officer | A | Stock Options | 167088 | $0.00 | 442,176.0000 | 0 | 60.74% | 0.00% |